25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biotest Aktiengesellschaft
Buy, Hold or Sell?

Let's analyze Biotest Aktiengesellschaft together

I guess you are interested in Biotest Aktiengesellschaft. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biotest Aktiengesellschaft. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biotest Aktiengesellschaft

I send you an email if I find something interesting about Biotest Aktiengesellschaft.

1. Quick Overview

1.1. Quick analysis of Biotest Aktiengesellschaft (30 sec.)










1.2. What can you expect buying and holding a share of Biotest Aktiengesellschaft? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€13.54
Expected worth in 1 year
€17.65
How sure are you?
36.8%

+ What do you gain per year?

Total Gains per Share
€4.10
Return On Investment
9.9%

For what price can you sell your share?

Current Price per Share
€41.40
Expected price per share
€41.20 - €42.40
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biotest Aktiengesellschaft (5 min.)




Live pricePrice per Share (EOD)
€41.40
Intrinsic Value Per Share
€63.73 - €76.90
Total Value Per Share
€77.27 - €90.45

2.2. Growth of Biotest Aktiengesellschaft (5 min.)




Is Biotest Aktiengesellschaft growing?

Current yearPrevious yearGrowGrow %
How rich?$584.7m$392.6m$159m28.8%

How much money is Biotest Aktiengesellschaft making?

Current yearPrevious yearGrowGrow %
Making money$52.4m-$2.7m$55.1m105.2%
Net Profit Margin21.5%-3.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Biotest Aktiengesellschaft (5 min.)




2.4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#94 / 339

Most Revenue
#154 / 339

Most Profit
#84 / 339
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biotest Aktiengesellschaft?

Welcome investor! Biotest Aktiengesellschaft's management wants to use your money to grow the business. In return you get a share of Biotest Aktiengesellschaft.

First you should know what it really means to hold a share of Biotest Aktiengesellschaft. And how you can make/lose money.

Speculation

The Price per Share of Biotest Aktiengesellschaft is €41.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotest Aktiengesellschaft.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotest Aktiengesellschaft, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €13.54. Based on the TTM, the Book Value Change Per Share is €1.03 per quarter. Based on the YOY, the Book Value Change Per Share is €0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotest Aktiengesellschaft.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.270.6%1.323.2%-0.07-0.2%0.090.2%0.080.2%
Usd Book Value Change Per Share0.220.5%1.122.7%0.100.2%0.781.9%0.781.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.220.5%1.122.7%0.100.2%0.781.9%0.781.9%
Usd Price Per Share45.39-46.05-46.08-38.80-37.62-
Price to Earnings Ratio42.43-17.78-34.43-25.07-22.79-
Price-to-Total Gains Ratio205.77-81.45--14.82--75.48--75.48-
Price to Book Ratio3.07-3.32-4.65-3.29-2.99-
Price-to-Total Gains Ratio205.77-81.45--14.82--75.48--75.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share45.17568
Number of shares22
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.120.78
Usd Total Gains Per Share1.120.78
Gains per Quarter (22 shares)24.6317.11
Gains per Year (22 shares)98.5268.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10998906858
201971880137126
302962870205194
403943860274262
504934850342330
605915840411398
706906830479466
807887820548534
908878810616602
1009859800684670

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%6.06.00.050.0%7.012.00.036.8%7.012.00.036.8%7.012.00.036.8%
Book Value Change Per Share4.00.00.0100.0%6.06.00.050.0%7.012.00.036.8%7.012.00.036.8%7.012.00.036.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.019.00.0%0.00.019.00.0%0.00.019.00.0%
Total Gains per Share4.00.00.0100.0%6.06.00.050.0%7.012.00.036.8%7.012.00.036.8%7.012.00.036.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biotest Aktiengesellschaft compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2021.026-80%0.094+116%0.713-72%0.713-72%
Book Value Per Share--13.54312.778+6%9.094+49%10.269+32%9.335+45%
Current Ratio--2.4532.863-14%4.741-48%4.430-45%4.281-43%
Debt To Asset Ratio--0.6100.638-4%0.693-12%0.636-4%0.626-2%
Debt To Equity Ratio--1.5671.768-11%2.255-31%1.782-12%1.722-9%
Dividend Per Share----0%-0%-0%-0%
Eps--0.2451.214-80%-0.063+126%0.083+195%0.076+224%
Free Cash Flow Per Share--1.4760.540+173%-0.926+163%-0.119+108%-0.119+108%
Free Cash Flow To Equity Per Share--1.4760.540+173%-0.926+163%-0.119+108%-0.119+108%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--76.904--------
Intrinsic Value_10Y_min--63.731--------
Intrinsic Value_1Y_max--0.896--------
Intrinsic Value_1Y_min--0.876--------
Intrinsic Value_3Y_max--7.883--------
Intrinsic Value_3Y_min--7.421--------
Intrinsic Value_5Y_max--21.127--------
Intrinsic Value_5Y_min--19.163--------
Market Cap--1646172403.2001669915274.400-1%1670904560.700-1%1363137592.770+21%1239215993.427+33%
Net Profit Margin--0.0620.215-71%-0.038+161%-0.014+122%-0.012+119%
Operating Margin----0%-0%-0.0070%-0.0020%
Operating Ratio--1.5111.328+14%1.735-13%1.697-11%1.702-11%
Pb Ratio3.0570%3.0723.316-7%4.649-34%3.286-7%2.987+3%
Pe Ratio42.2230%42.42717.778+139%34.430+23%25.068+69%22.789+86%
Price Per Share41.4000%41.60042.200-1%42.225-1%35.558+17%34.473+21%
Price To Free Cash Flow Ratio7.0130%7.04714.175-50%-13.117+286%-0.896+113%-0.814+112%
Price To Total Gains Ratio204.7820%205.77281.454+153%-14.823+107%-75.484+137%-75.484+137%
Quick Ratio--0.4970.743-33%1.143-57%1.064-53%1.044-52%
Return On Assets--0.0070.035-80%-0.003+136%0.001+578%0.001+584%
Return On Equity--0.0180.100-82%-0.008+146%0.003+420%0.003+441%
Total Gains Per Share--0.2021.026-80%0.094+116%0.713-72%0.713-72%
Usd Book Value--584774080.000551765280.000+6%392695600.000+49%470225360.000+24%476586560.000+23%
Usd Book Value Change Per Share--0.2211.120-80%0.102+116%0.778-72%0.778-72%
Usd Book Value Per Share--14.77813.944+6%9.924+49%11.205+32%10.186+45%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.2671.325-80%-0.069+126%0.091+195%0.082+224%
Usd Free Cash Flow--63726080.00023324400.000+173%-39965200.000+163%-6138000.000+110%-5986720.000+109%
Usd Free Cash Flow Per Share--1.6100.589+173%-1.010+163%-0.129+108%-0.129+108%
Usd Free Cash Flow To Equity Per Share--1.6100.589+173%-1.010+163%-0.129+108%-0.129+108%
Usd Market Cap--1796303326.3721822211547.425-1%1823291056.636-1%1487455741.231+21%1352232492.028+33%
Usd Price Per Share45.1760%45.39446.049-1%46.076-1%38.800+17%37.617+21%
Usd Profit--10584640.00052432160.000-80%-2728000.000+126%3322704.000+219%3119840.000+239%
Usd Revenue--171100160.000220722480.000-22%146820960.000+17%154088352.000+11%149757280.000+14%
Usd Total Gains Per Share--0.2211.120-80%0.102+116%0.778-72%0.778-72%
 EOD+4 -2MRQTTM+14 -18YOY+25 -75Y+23 -910Y+22 -10

3.3 Fundamental Score

Let's check the fundamental score of Biotest Aktiengesellschaft based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1542.223
Price to Book Ratio (EOD)Between0-13.057
Net Profit Margin (MRQ)Greater than00.062
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.497
Current Ratio (MRQ)Greater than12.453
Debt to Asset Ratio (MRQ)Less than10.610
Debt to Equity Ratio (MRQ)Less than11.567
Return on Equity (MRQ)Greater than0.150.018
Return on Assets (MRQ)Greater than0.050.007
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Biotest Aktiengesellschaft based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose41.600
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Biotest Aktiengesellschaft

  • Other
  • 0

There is no Profile data available for BIO.BE.

Fundamental data was last updated by Penke on 2024-10-01 10:37:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biotest Aktiengesellschaft earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A Net Profit Margin of 6.2% means that €0.06 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotest Aktiengesellschaft:

  • The MRQ is 6.2%. The company is making a profit. +1
  • The TTM is 21.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ6.2%TTM21.5%-15.3%
TTM21.5%YOY-3.8%+25.3%
TTM21.5%5Y-1.4%+22.9%
5Y-1.4%10Y-1.2%-0.2%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2%6.2%0.0%
TTM21.5%5.8%+15.7%
YOY-3.8%5.8%-9.6%
5Y-1.4%6.1%-7.5%
10Y-1.2%6.2%-7.4%
4.3.1.2. Return on Assets

Shows how efficient Biotest Aktiengesellschaft is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • 0.7% Return on Assets means that Biotest Aktiengesellschaft generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 3.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.7%TTM3.5%-2.8%
TTM3.5%YOY-0.3%+3.7%
TTM3.5%5Y0.1%+3.4%
5Y0.1%10Y0.1%+0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7%1.3%-0.6%
TTM3.5%1.1%+2.4%
YOY-0.3%1.4%-1.7%
5Y0.1%1.2%-1.1%
10Y0.1%1.4%-1.3%
4.3.1.3. Return on Equity

Shows how efficient Biotest Aktiengesellschaft is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • 1.8% Return on Equity means Biotest Aktiengesellschaft generated €0.02 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 10.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.8%TTM10.0%-8.2%
TTM10.0%YOY-0.8%+10.8%
TTM10.0%5Y0.3%+9.7%
5Y0.3%10Y0.3%+0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%3.6%-1.8%
TTM10.0%3.4%+6.6%
YOY-0.8%4.4%-5.2%
5Y0.3%3.8%-3.5%
10Y0.3%3.8%-3.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biotest Aktiengesellschaft.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biotest Aktiengesellschaft is operating .

  • Measures how much profit Biotest Aktiengesellschaft makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.7%+0.7%
5Y-0.7%10Y-0.2%-0.5%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.4%-8.4%
TTM-5.0%-5.0%
YOY-7.7%-7.7%
5Y-0.7%4.9%-5.6%
10Y-0.2%6.8%-7.0%
4.3.2.2. Operating Ratio

Measures how efficient Biotest Aktiengesellschaft is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 1.51 means that the operating costs are €1.51 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.511. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.328. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.511TTM1.328+0.183
TTM1.328YOY1.735-0.406
TTM1.3285Y1.697-0.369
5Y1.69710Y1.702-0.005
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5111.279+0.232
TTM1.3281.344-0.016
YOY1.7351.340+0.395
5Y1.6971.291+0.406
10Y1.7021.379+0.323
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biotest Aktiengesellschaft.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biotest Aktiengesellschaft is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 2.45 means the company has €2.45 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 2.453. The company is able to pay all its short-term debts. +1
  • The TTM is 2.863. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.453TTM2.863-0.410
TTM2.863YOY4.741-1.878
TTM2.8635Y4.430-1.567
5Y4.43010Y4.281+0.149
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4531.423+1.030
TTM2.8631.466+1.397
YOY4.7411.568+3.173
5Y4.4301.555+2.875
10Y4.2811.498+2.783
4.4.3.2. Quick Ratio

Measures if Biotest Aktiengesellschaft is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A Quick Ratio of 0.50 means the company can pay off €0.50 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.497. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.743. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.497TTM0.743-0.246
TTM0.743YOY1.143-0.400
TTM0.7435Y1.064-0.321
5Y1.06410Y1.044+0.019
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4970.542-0.045
TTM0.7430.554+0.189
YOY1.1430.579+0.564
5Y1.0640.607+0.457
10Y1.0440.608+0.436
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biotest Aktiengesellschaft.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biotest Aktiengesellschaft assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biotest Aktiengesellschaft to Other industry mean.
  • A Debt to Asset Ratio of 0.61 means that Biotest Aktiengesellschaft assets are financed with 61.0% credit (debt) and the remaining percentage (100% - 61.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 0.610. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.638. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.610TTM0.638-0.027
TTM0.638YOY0.693-0.055
TTM0.6385Y0.636+0.002
5Y0.63610Y0.626+0.010
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6100.527+0.083
TTM0.6380.534+0.104
YOY0.6930.545+0.148
5Y0.6360.553+0.083
10Y0.6260.563+0.063
4.5.4.2. Debt to Equity Ratio

Measures if Biotest Aktiengesellschaft is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A Debt to Equity ratio of 156.7% means that company has €1.57 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotest Aktiengesellschaft:

  • The MRQ is 1.567. The company is just able to pay all its debts with equity.
  • The TTM is 1.768. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.567TTM1.768-0.200
TTM1.768YOY2.255-0.488
TTM1.7685Y1.782-0.015
5Y1.78210Y1.722+0.060
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5671.110+0.457
TTM1.7681.130+0.638
YOY2.2551.236+1.019
5Y1.7821.318+0.464
10Y1.7221.435+0.287
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Biotest Aktiengesellschaft generates.

  • Above 15 is considered overpriced but always compare Biotest Aktiengesellschaft to the Other industry mean.
  • A PE ratio of 42.43 means the investor is paying €42.43 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 42.223. Based on the earnings, the company is overpriced. -1
  • The MRQ is 42.427. Based on the earnings, the company is overpriced. -1
  • The TTM is 17.778. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD42.223MRQ42.427-0.204
MRQ42.427TTM17.778+24.649
TTM17.778YOY34.430-16.652
TTM17.7785Y25.068-7.289
5Y25.06810Y22.789+2.279
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD42.22314.018+28.205
MRQ42.42712.120+30.307
TTM17.77811.675+6.103
YOY34.43011.291+23.139
5Y25.06812.102+12.966
10Y22.78912.409+10.380
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 7.013. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.047. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 14.175. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.013MRQ7.047-0.034
MRQ7.047TTM14.175-7.128
TTM14.175YOY-13.117+27.292
TTM14.1755Y-0.896+15.070
5Y-0.89610Y-0.814-0.081
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD7.0139.380-2.367
MRQ7.0478.337-1.290
TTM14.1757.122+7.053
YOY-13.1171.440-14.557
5Y-0.8962.775-3.671
10Y-0.8144.090-4.904
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biotest Aktiengesellschaft is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 3.07 means the investor is paying €3.07 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotest Aktiengesellschaft:

  • The EOD is 3.057. Based on the equity, the company is fair priced.
  • The MRQ is 3.072. Based on the equity, the company is fair priced.
  • The TTM is 3.316. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.057MRQ3.072-0.015
MRQ3.072TTM3.316-0.244
TTM3.316YOY4.649-1.332
TTM3.3165Y3.286+0.031
5Y3.28610Y2.987+0.299
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD3.0571.596+1.461
MRQ3.0721.400+1.672
TTM3.3161.408+1.908
YOY4.6491.379+3.270
5Y3.2861.640+1.646
10Y2.9871.697+1.290
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets1,375,800
Total Liabilities839,900
Total Stockholder Equity535,900
 As reported
Total Liabilities 839,900
Total Stockholder Equity+ 535,900
Total Assets = 1,375,800

Assets

Total Assets1,375,800
Total Current Assets738,900
Long-term Assets636,900
Total Current Assets
Cash And Cash Equivalents 66,300
Short-term Investments 18,400
Net Receivables 131,300
Inventory 472,500
Other Current Assets 10,700
Total Current Assets  (as reported)738,900
Total Current Assets  (calculated)699,200
+/- 39,700
Long-term Assets
Property Plant Equipment 575,400
Long-term Assets Other 100
Long-term Assets  (as reported)636,900
Long-term Assets  (calculated)575,500
+/- 61,400

Liabilities & Shareholders' Equity

Total Current Liabilities301,200
Long-term Liabilities538,700
Total Stockholder Equity535,900
Total Current Liabilities
Accounts payable 69,400
Other Current Liabilities 17,200
Total Current Liabilities  (as reported)301,200
Total Current Liabilities  (calculated)86,600
+/- 214,600
Long-term Liabilities
Long-term Liabilities  (as reported)538,700
Long-term Liabilities  (calculated)0
+/- 538,700
Total Stockholder Equity
Retained Earnings 276,500
Total Stockholder Equity (as reported)535,900
Total Stockholder Equity (calculated)276,500
+/- 259,400
Other
Capital Stock39,600
Common Stock Shares Outstanding 39,571
Net Invested Capital 535,900
Net Working Capital 437,700
Property Plant and Equipment Gross 575,400



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
1,044,600
1,058,200
1,091,000
1,108,400
1,107,600
1,145,200
1,122,200
1,131,300
1,134,800
1,145,800
1,135,400
1,104,200
1,109,800
1,101,900
1,079,300
1,203,000
1,190,200
1,214,100
1,349,500
1,410,900
1,446,800
1,375,800
1,375,8001,446,8001,410,9001,349,5001,214,1001,190,2001,203,0001,079,3001,101,9001,109,8001,104,2001,135,4001,145,8001,134,8001,131,3001,122,2001,145,2001,107,6001,108,4001,091,0001,058,2001,044,600
   > Total Current Assets 
476,100
488,600
508,500
522,800
525,600
563,900
542,200
556,300
560,600
570,500
556,600
522,200
523,900
522,000
497,500
619,400
597,400
620,700
736,200
756,500
796,200
738,900
738,900796,200756,500736,200620,700597,400619,400497,500522,000523,900522,200556,600570,500560,600556,300542,200563,900525,600522,800508,500488,600476,100
       Cash And Cash Equivalents 
43,400
49,800
65,500
60,800
44,000
63,700
40,200
71,300
55,000
72,000
79,200
104,400
115,300
85,000
53,300
116,600
68,000
58,300
65,400
108,100
84,700
66,300
66,30084,700108,10065,40058,30068,000116,60053,30085,000115,300104,40079,20072,00055,00071,30040,20063,70044,00060,80065,50049,80043,400
       Short-term Investments 
52,500
31,900
34,100
24,900
20,600
31,000
32,800
17,900
13,300
13,100
12,100
13,100
14,800
18,100
23,600
20,000
18,900
12,600
13,400
10,400
14,100
18,400
18,40014,10010,40013,40012,60018,90020,00023,60018,10014,80013,10012,10013,10013,30017,90032,80031,00020,60024,90034,10031,90052,500
       Net Receivables 
94,200
108,400
104,800
107,700
93,300
112,600
108,900
115,800
122,400
115,100
107,400
107,300
86,200
97,200
93,400
124,500
120,400
149,300
210,300
145,200
201,000
131,300
131,300201,000145,200210,300149,300120,400124,50093,40097,20086,200107,300107,400115,100122,400115,800108,900112,60093,300107,700104,800108,40094,200
       Inventory 
236,000
247,000
257,300
280,100
312,400
304,300
306,900
290,100
301,800
303,100
298,100
244,600
255,800
263,200
268,700
293,800
327,600
341,100
373,600
419,100
438,700
472,500
472,500438,700419,100373,600341,100327,600293,800268,700263,200255,800244,600298,100303,100301,800290,100306,900304,300312,400280,100257,300247,000236,000
       Other Current Assets 
12,900
10,100
6,900
1,400
9,600
8,400
9,700
1,200
18,700
13,400
12,100
3,100
18,000
15,400
23,600
3,100
20,400
15,300
29,300
2,700
12,200
10,700
10,70012,2002,70029,30015,30020,4003,10023,60015,40018,0003,10012,10013,40018,7001,2009,7008,4009,6001,4006,90010,10012,900
   > Long-term Assets 
568,500
569,600
582,500
585,600
582,000
581,300
580,000
575,000
574,200
575,300
578,800
582,000
585,900
579,900
581,800
583,600
592,700
593,400
613,300
654,400
650,600
636,900
636,900650,600654,400613,300593,400592,700583,600581,800579,900585,900582,000578,800575,300574,200575,000580,000581,300582,000585,600582,500569,600568,500
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
543,800
547,800
549,600
555,700
573,400
578,400
581,100
575,400
575,400581,100578,400573,400555,700549,600547,800543,80000000000000000
       Goodwill 
0
0
0
7,200
0
0
0
7,100
0
0
0
7,100
0
0
0
7,200
0
0
0
6,000
0
0
006,0000007,2000007,1000007,1000007,200000
       Intangible Assets 
0
0
0
6,600
0
0
0
6,900
0
0
0
4,100
0
0
0
9,200
0
0
0
9,000
0
0
009,0000009,2000004,1000006,9000006,600000
       Long-term Assets Other 
100
569,600
7,700
100
5,600
3,600
3,700
100
300
100
100
400
500
300
500
100
200
200
200
100
100
100
1001001002002002001005003005004001001003001003,7003,6005,6001007,700569,600100
> Total Liabilities 
550,700
562,000
599,300
631,500
641,400
685,900
678,000
689,700
707,100
723,400
723,200
723,800
734,700
743,200
735,500
831,900
839,100
840,600
889,600
912,000
918,900
839,900
839,900918,900912,000889,600840,600839,100831,900735,500743,200734,700723,800723,200723,400707,100689,700678,000685,900641,400631,500599,300562,000550,700
   > Total Current Liabilities 
107,800
415,600
101,100
115,000
123,100
113,800
103,300
105,600
121,100
111,100
103,800
106,400
114,900
122,200
109,600
130,200
129,500
122,800
147,200
385,300
391,200
301,200
301,200391,200385,300147,200122,800129,500130,200109,600122,200114,900106,400103,800111,100121,100105,600103,300113,800123,100115,000101,100415,600107,800
       Short-term Debt 
0
0
0
3,300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000003,300000
       Short Long Term Debt 
0
0
0
3,300
0
0
0
3,500
0
0
0
1,600
0
0
0
4,800
0
0
0
226,800
0
0
00226,8000004,8000001,6000003,5000003,300000
       Accounts payable 
50,600
63,300
40,100
52,200
54,700
49,000
37,700
42,000
49,300
43,800
31,500
38,800
38,700
42,200
30,200
51,100
44,700
54,500
53,300
78,100
77,200
69,400
69,40077,20078,10053,30054,50044,70051,10030,20042,20038,70038,80031,50043,80049,30042,00037,70049,00054,70052,20040,10063,30050,600
       Other Current Liabilities 
25,700
28,900
30,400
7,700
33,100
34,700
33,500
5,900
35,400
39,100
39,500
4,300
14,900
18,900
11,900
4,900
21,100
18,300
20,800
5,800
16,500
17,200
17,20016,5005,80020,80018,30021,1004,90011,90018,90014,9004,30039,50039,10035,4005,90033,50034,70033,1007,70030,40028,90025,700
   > Long-term Liabilities 
442,900
146,400
498,200
516,500
518,300
572,100
574,700
584,100
586,000
612,300
619,400
617,400
619,800
621,000
625,900
701,700
709,600
717,800
742,400
526,700
527,700
538,700
538,700527,700526,700742,400717,800709,600701,700625,900621,000619,800617,400619,400612,300586,000584,100574,700572,100518,300516,500498,200146,400442,900
       Capital Lease Obligations Min Short Term Debt
0
0
0
23,400
0
0
0
27,400
0
0
0
26,800
0
0
0
29,000
0
0
0
57,800
0
0
0057,80000029,00000026,80000027,40000023,400000
       Long-term Liabilities Other 
100
200
200
300
100
0
0
-600
0
0
0
-1,900
0
0
100
-700
0
0
0
-300
0
0
00-300000-70010000-1,900000-60000100300200200100
> Total Stockholder Equity
493,900
496,200
491,700
476,900
466,200
459,300
444,200
441,600
427,700
422,400
412,200
380,400
375,100
358,700
343,800
371,100
351,100
373,500
459,900
498,900
527,900
535,900
535,900527,900498,900459,900373,500351,100371,100343,800358,700375,100380,400412,200422,400427,700441,600444,200459,300466,200476,900491,700496,200493,900
   Common Stock0000000000000000000000
   Retained Earnings 
52,900
234,800
232,300
217,500
206,800
199,900
184,800
182,200
168,300
163,000
152,800
121,000
115,700
99,300
84,400
111,700
91,700
114,100
200,500
239,500
268,500
276,500
276,500268,500239,500200,500114,10091,700111,70084,40099,300115,700121,000152,800163,000168,300182,200184,800199,900206,800217,500232,300234,80052,900
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 0000000000000000000000



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue684,600
Cost of Revenue-404,300
Gross Profit280,300280,300
 
Operating Income (+$)
Gross Profit280,300
Operating Expense-564,500
Operating Income120,100-284,200
 
Operating Expense (+$)
Research Development66,800
Selling General Administrative81,000
Selling And Marketing Expenses0
Operating Expense564,500147,800
 
Net Interest Income (+$)
Interest Income2,000
Interest Expense-40,000
Other Finance Cost-200
Net Interest Income-38,200
 
Pretax Income (+$)
Operating Income120,100
Net Interest Income-38,200
Other Non-Operating Income Expenses0
Income Before Tax (EBT)106,300120,100
EBIT - interestExpense = -40,000
127,000
167,000
Interest Expense40,000
Earnings Before Interest and Taxes (EBIT)0146,300
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax106,300
Tax Provision--20,700
Net Income From Continuing Ops127,000127,000
Net Income127,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net038,200
 

Technical Analysis of Biotest Aktiengesellschaft
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biotest Aktiengesellschaft. The general trend of Biotest Aktiengesellschaft is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biotest Aktiengesellschaft's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biotest Aktiengesellschaft.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 42.40 < 42.40 < 42.40.

The bearish price targets are: 41.20 > 41.20 > 41.20.

Tweet this
Biotest Aktiengesellschaft Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biotest Aktiengesellschaft. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biotest Aktiengesellschaft Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Moving Average Convergence/Divergence (MACD) ChartBiotest Aktiengesellschaft Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biotest Aktiengesellschaft. The current adx is .

Biotest Aktiengesellschaft Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Relative Strength Index (RSI) ChartBiotest Aktiengesellschaft Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Stochastic Oscillator ChartBiotest Aktiengesellschaft Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Commodity Channel Index (CCI) ChartBiotest Aktiengesellschaft Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Chande Momentum Oscillator (CMO) ChartBiotest Aktiengesellschaft Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Williams %R ChartBiotest Aktiengesellschaft Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Average True Range (ATR) ChartBiotest Aktiengesellschaft Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily On-Balance Volume (OBV) ChartBiotest Aktiengesellschaft Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biotest Aktiengesellschaft.

Biotest Aktiengesellschaft Daily Money Flow Index (MFI) ChartBiotest Aktiengesellschaft Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biotest Aktiengesellschaft.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-05-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-06-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Biotest Aktiengesellschaft Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biotest Aktiengesellschaft based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose41.600
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biotest Aktiengesellschaft with someone you think should read this too:
  • Are you bullish or bearish on Biotest Aktiengesellschaft? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biotest Aktiengesellschaft? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biotest Aktiengesellschaft

I send you an email if I find something interesting about Biotest Aktiengesellschaft.


Comments

How you think about this?

Leave a comment

Stay informed about Biotest Aktiengesellschaft.

Receive notifications about Biotest Aktiengesellschaft in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.